A study followed 103 adults with class II or III obesity after sleeve gastrectomy [1]. The evidence on treating weight regain after bariatric surgery addresses a different stage of recovery. In this study, semaglutide began soon after surgery.
What happened at six and twelve months
Forty-eight patients received semaglutide from postoperative month one through month six. The other 55 did not receive semaglutide. At six months, total weight loss averaged 29.74% and 26.32%, respectively. At twelve months, the averages were 35.14% and 30.73% (p = 0.002) [1].
Total weight loss includes weight lost from before surgery. The gap was visible about six months after the scheduled end of treatment. Differences between the groups may account for some or all of the gap.
What the study can tell patients
The study used one center and did not assign treatment at random. Research on GLP-1 timing around bariatric surgery includes studies with other start times. This study did not test which start time works best. Decisions after surgery belong with the bariatric care team.